- Home
- ALXO vs ANNA Comparison
ALXO vs ANNA Comparison
Compare ALXO & ANNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- ANNA
- Stock Information
- Founded
- ALXO 2015
- ANNA 2007
- Country
- ALXO United States
- ANNA United States
- Employees
- ALXO N/A
- ANNA N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- ANNA
- Sector
- ALXO Health Care
- ANNA
- Exchange
- ALXO Nasdaq
- ANNA NYSE
- Market Cap
- ALXO 76.5M
- ANNA 90.3M
- IPO Year
- ALXO 2020
- ANNA N/A
- Fundamental
- Price
- ALXO $1.74
- ANNA $9.50
- Analyst Decision
- ALXO Buy
- ANNA
- Analyst Count
- ALXO 6
- ANNA 0
- Target Price
- ALXO $11.00
- ANNA N/A
- AVG Volume (30 Days)
- ALXO 1.1M
- ANNA 20.6K
- Earning Date
- ALXO 03-06-2025
- ANNA 01-01-0001
- Dividend Yield
- ALXO N/A
- ANNA N/A
- EPS Growth
- ALXO N/A
- ANNA N/A
- EPS
- ALXO N/A
- ANNA N/A
- Revenue
- ALXO N/A
- ANNA $648,328.00
- Revenue This Year
- ALXO N/A
- ANNA N/A
- Revenue Next Year
- ALXO N/A
- ANNA N/A
- P/E Ratio
- ALXO N/A
- ANNA N/A
- Revenue Growth
- ALXO N/A
- ANNA N/A
- 52 Week Low
- ALXO $1.19
- ANNA $5.82
- 52 Week High
- ALXO $17.83
- ANNA $18.70
- Technical
- Relative Strength Index (RSI)
- ALXO 53.13
- ANNA N/A
- Support Level
- ALXO $1.56
- ANNA N/A
- Resistance Level
- ALXO $1.94
- ANNA N/A
- Average True Range (ATR)
- ALXO 0.16
- ANNA 0.00
- MACD
- ALXO -0.01
- ANNA 0.00
- Stochastic Oscillator
- ALXO 50.00
- ANNA 0.00
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About ANNA ALEANNA INC
AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy.